NASDAQ

Spero Therapeutics, Inc. (SPRO)

♥ 605 Thanks from members

Live price chart, market sentiment, and community perspectives for Spero Therapeutics, Inc. (NASDAQ: SPRO).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Ankit MahadeviaLeadership: Ankit Mahadevia (CEO)Leadership: Darrell Quan (CFO)Holder: Sofinnova InvestmentsHolder: RA Capital ManagementHolder: BVF PartnersTebipenem HBr (oral carbapenem)SPR741#Spero Therapeutics#SPRO stock#antibiotic development#tebipenem#antimicrobial resistance